Diclofenac Sodium Prices, Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data Report 2026 Edition
Diclofenac Sodium Price Trend, Index and Forecast
Track the latest insights on diclofenac sodium price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Diclofenac Sodium Prices Outlook Q4 2025
- USA: USD 16734/MT
- China: USD 13242/MT
- Germany: USD 16942/MT
- India: USD 14630/MT
- Brazil: USD 13648/MT
Diclofenac Sodium Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the fourth quarter of 2025, diclofenac sodium prices in the USA reached 16734 USD/MT in December. The upward price movement was primarily influenced by firm pharmaceutical demand and stable procurement from downstream formulation manufacturers. Supply chain discipline among domestic distributors supported market confidence, while controlled import volumes limited price erosion. Elevated production costs related to compliance and quality assurance further reinforced pricing strength.
During the fourth quarter of 2025, diclofenac sodium prices in China reached 13242 USD/MT in December. Prices softened due to subdued export demand and ample availability from domestic manufacturers. Increased production efficiency and sufficient inventories led suppliers to adopt competitive pricing strategies. Weaker international inquiries and cautious procurement behavior from overseas buyers further pressured prices.
During the fourth quarter of 2025, diclofenac sodium prices in Germany reached 16942 USD/MT in December. The market experienced firm pricing due to strong pharmaceutical manufacturing demand and adherence to stringent quality standards. Supply remained controlled, as producers prioritized contractual deliveries. Higher compliance-related operational costs supported elevated price levels.
During the fourth quarter of 2025, diclofenac sodium prices in India reached 14630 USD/MT in December. Prices declined as export demand softened and domestic supply remained ample. Competitive market conditions among manufacturers led to price adjustments to stimulate sales. Stable availability of intermediates reduced production cost pressures. Additionally, cautious buying activity from international pharmaceutical companies limited upward momentum.
During the fourth quarter of 2025, diclofenac sodium prices in Brazil reached 13648 USD/MT in December. The market observed declining prices due to steady import inflows and moderate pharmaceutical demand. Buyers adopted a cautious procurement approach amid sufficient availability. Competitive supplier offerings and stable logistics conditions reduced urgency in purchasing.
Diclofenac Sodium Prices Outlook Q3 2025
- USA: USD 16294/MT
- China: USD 13554/MT
- Germany: USD 16370/MT
- India: USD 15130/MT
- Brazil: USD 13955/MT
During the third quarter of 2025, the diclofenac sodium prices in the USA reached 16294 USD/MT in September. Prices moved upward as demand from pharmaceutical formulation units and hospital supply chains strengthened. Higher procurement for pain management and anti-inflammatory formulations supported buying activity. Buyers aligned sourcing with production schedules and regulatory requirements, while stable API availability influenced purchasing decisions.
During the third quarter of 2025, the diclofenac sodium prices in China reached 13554 USD/MT in September. Prices declined due to softer export demand and sufficient domestic supply. Reduced overseas orders and cautious distributor purchasing influenced procurement volumes. Buyers focused on inventory optimization and short-term sourcing aligned with confirmed formulation needs.
During the third quarter of 2025, the diclofenac sodium prices in Germany reached 16370 USD/MT in September. Prices increased as demand from regulated pharmaceutical manufacturing and hospital supply chains improved. Higher offtake for compliant and traceable material supported procurement. Buyers coordinated sourcing with production planning and documentation requirements.
During the third quarter of 2025, the diclofenac sodium prices in India reached 15130 USD/MT in September. Prices moved upward due to strong demand from domestic formulation units and export-oriented pharmaceutical manufacturers. Increased supplies to regulated and semi-regulated markets supported consumption. Buyers aligned procurement with manufacturing schedules and compliance timelines.
During the third quarter of 2025, the diclofenac sodium prices in Brazil reached 13955 USD/MT in September. Prices declined amid reduced public healthcare procurement and cautious distributor purchasing. Adequate import availability influenced sourcing behavior. Buyers limited purchases to near-term operational requirements.
Diclofenac Sodium Prices Outlook Q2 2025
- USA: USD 15912/MT
- China: USD 13930/MT
- Germany: USD 16080/MT
- India: USD 14660/MT
- Brazil: USD 14476/MT
During the second quarter of 2025, the diclofenac sodium prices in the USA reached 15912 USD/MT in June. Demand from pharmaceutical formulation and hospital supply channels influenced procurement activity. Buyers aligned sourcing with production schedules and inventory planning.
During the second quarter of 2025, the diclofenac sodium prices in China reached 13930 USD/MT in June. Consumption from export-oriented API manufacturing shaped procurement patterns. Domestic production capacity and inventory availability supported material access.
During the second quarter of 2025, the diclofenac sodium prices in Germany reached 16080 USD/MT in June. Demand from pharmaceutical distributors and formulation units guided sourcing decisions. Buyers coordinated procurement with regulatory compliance and batch documentation requirements.
During the second quarter of 2025, the diclofenac sodium prices in India reached 14660 USD/MT in June. Procurement was influenced by export demand and domestic formulation requirements. Buyers structured sourcing around confirmed manufacturing schedules.
During the second quarter of 2025, the diclofenac sodium prices in Brazil reached 14476 USD/MT in June. Demand from public healthcare tenders and pharmaceutical distributors shaped procurement volumes. Import availability and logistics considerations influenced sourcing timelines.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing diclofenac sodium prices.
Europe Diclofenac Sodium Price Trend
Q4 2025:
The diclofenac sodium price index in Europe reflected bullish conditions supported by stable pharmaceutical production and strict regulatory compliance across major manufacturing hubs. Regional producers operated under controlled output levels to meet quality and safety requirements, which limited supply flexibility and supported elevated prices. Dependence on certified and qualified manufacturers further restricted alternative sourcing options, strengthening supplier positioning. Consistent demand from healthcare and pharmaceutical formulation sectors ensured regular offtake, preventing inventory accumulation.
Q3 2025:
As per the diclofenac sodium price index, Europe experienced upward price movement, led by increases in Germany. Demand from regulated pharmaceutical manufacturing and hospital supply chains supported regional consumption. German buyers increased sourcing for compliant material meeting strict regulatory and documentation standards. Procurement strategies emphasized securing traceable supply for ongoing formulation runs. Regional production and import availability supported continuity, with sourcing aligned closely to confirmed prescription demand and manufacturing schedules.
Q2 2025:
In Europe, diclofenac sodium demand was shaped by routine pharmaceutical formulation activity and distributor-led sourcing across regulated markets. Buyers coordinated procurement with production planning, quality assurance protocols, and documentation requirements. Import availability and established logistics networks supported material access. Purchasing strategies focused on maintaining uninterrupted supply for hospital and retail pharmaceutical channels.
This analysis can be extended to include detailed diclofenac sodium price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Diclofenac Sodium Price Trend
Q4 2025:
The diclofenac sodium price index in North America remained strong due to steady pharmaceutical demand and disciplined inventory management practices across the region. Pharmaceutical manufacturers maintained consistent production schedules, ensuring regular consumption of active pharmaceutical ingredients. Suppliers benefited from stable procurement patterns, as buyers prioritized supply security and compliance over aggressive price negotiations. Compliance-driven production and documentation requirements sustained higher cost structures, providing firm price support.
Q3 2025:
As per the diclofenac sodium price index, North America experienced upward price movement, driven by increases in the USA. Demand from hospital procurement programs and pharmaceutical formulation units supported consumption. Buyers advanced sourcing to meet prescription demand and inventory requirements. Domestic distribution networks and import availability supported supply continuity, while procurement decisions remained aligned with confirmed healthcare demand.
Q2 2025:
In North America, diclofenac sodium demand reflected procurement aligned with pharmaceutical formulation schedules and hospital supply planning. Buyers coordinated sourcing with inventory management and regulatory compliance. Import flows and established supplier relationships supported material availability, while procurement strategies emphasized continuity for regulated manufacturing and healthcare distribution.
Specific diclofenac sodium historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Diclofenac Sodium Price Trend
Q4 2025:
As per the diclofenac sodium price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
Q3 2025:
The report explores the diclofenac sodium trends and diclofenac sodium price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on diclofenac sodium prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Diclofenac Sodium Price Trend
Q4 2025:
During the fourth quarter of 2025, diclofenac sodium prices across the Asia Pacific region followed a downward trend due to ample supply availability and muted demand growth in several key markets. Regional manufacturers operated at stable production levels, resulting in sufficient inventories that reduced pricing pressure. Export demand from overseas pharmaceutical buyers softened, prompting suppliers to adopt more competitive pricing strategies to sustain order volumes. Additionally, buyers across the region displayed cautious procurement behavior, purchasing strictly on a need-based basis rather than engaging in bulk restocking.
Q3 2025:
Asia Pacific exhibited mixed price movement, with upward momentum in India and downward pressure in China. Strong demand from Indian formulation units supplying export markets supported consumption, while softer export orders reduced Chinese offtake. Buyers adjusted sourcing strategies based on country-specific demand visibility and regulatory destination requirements. Domestic production capacity and regional trade flows supported material availability across key manufacturing hubs.
Q2 2025:
In Asia Pacific, diclofenac sodium demand was shaped by pharmaceutical formulation activity across China and India. Buyers coordinated procurement with production planning, export order schedules, and compliance documentation requirements. Domestic supply availability and regional trade supported continuity, while procurement strategies emphasized operational alignment and batch traceability.
This diclofenac sodium price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Diclofenac Sodium Price Trend
Q4 2025:
Diclofenac sodium prices in Latin America softened due to sufficient import availability and moderate growth in pharmaceutical demand. The region’s reliance on imports ensured a steady supply, reducing urgency among buyers. Pharmaceutical manufacturers maintained cautious procurement strategies, aligning purchases closely with production schedules to avoid excess inventory. Competitive offerings from multiple international suppliers further influenced downward price adjustments. Demand from healthcare formulations remained stable but lacked strong growth momentum to support firmer prices.
Q3 2025:
Diclofenac sodium prices in Latin America moved downward, led by declines in Brazil. Reduced public healthcare procurement and cautious distributor purchasing softened regional consumption. Buyers limited sourcing volumes amid inventory optimization efforts. Import availability supported supply, allowing procurement to remain closely aligned with confirmed formulation and tender-based requirements.
Q2 2025:
In Latin America, diclofenac sodium procurement reflected demand from pharmaceutical distributors and formulation units supplying public and private healthcare channels. Buyers scheduled sourcing based on confirmed supply commitments and tender cycles. Import flows and logistics coordination supported material availability, while procurement strategies focused on ensuring continuity of supply.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Diclofenac Sodium Pricing Report, Market Analysis, and News
IMARC's latest publication, “Diclofenac Sodium Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the diclofenac sodium market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of diclofenac sodium at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed diclofenac sodium prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting diclofenac sodium pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Diclofenac Sodium Industry Analysis
The global diclofenac sodium industry size reached USD 2.2 Million in 2025. By 2034, IMARC Group expects the market to reach USD 3.3 Million, at a projected CAGR of 4.61% during 2026-2034. Market growth is driven by sustained demand for non-steroidal anti-inflammatory drugs, rising prevalence of chronic pain and inflammatory conditions, expanding generic pharmaceutical manufacturing, and continued reliance on diclofenac sodium across regulated healthcare markets worldwide.
Latest News and Developments:
- November 2025: A randomized clinical trial in Turkey found that diclofenac sodium significantly reduced postoperative pain when used as an intracanal medicament in endodontic treatment compared with calcium hydroxide or combination therapy. The study was conducted by researchers from the Department of Endodontics at Hatay Mustafa Kemal University and was published in “Odontology” following completion of patient follow-ups. It is aimed at establishing diclofenac sodium as a viable alternative for managing postoperative pain in root canal procedures and is drawing interest from dental clinicians exploring NSAID-based intracanal protocols.
Product Description
Diclofenac sodium is a nonsteroidal anti-inflammatory drug (NSAID) that lowers inflammation and acts as a pain reliever in conditions, such as arthritis or acute injuries. It works by blocking cyclooxygenase (COX)-1 and (COX)-2 enzymes that help to develop prostaglandins, which results in inflammation. It is created by a complex synthesis method that includes the condensation of phenylacetic acid derivatives. It can be found in diverse formats, such as oral tablets, topical gels, and injections, which allow adaptable usage based on the specific requirements of the patient and the severity of their condition. It offers immediate pain relief to control acute pain and elevate the quality of life. It notably reduces swelling and inflammation, therefore relieving swollen joints and local tissues. It can lead to a reduction in the dependency of other medications, like opioids, which have a higher likelihood of side effects and addiction.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Diclofenac Sodium |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Diclofenac Sodium Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of diclofenac sodium pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting diclofenac sodium price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The diclofenac sodium price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.